These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 9168171)

  • 1. Diminished production of type-I interferons and interleukin-2 in patients with multiple sclerosis.
    Wandinger KP; Wessel K; Neustock P; Siekhaus A; Kirchner H
    J Neurol Sci; 1997 Jul; 149(1):87-93. PubMed ID: 9168171
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of granulocyte colony-stimulating factor mobilization on phenotypical and functional properties of immune cells.
    Tayebi H; Kuttler F; Saas P; Lienard A; Petracca B; Lapierre V; Ferrand C; Fest T; Cahn J; Blaise D; Kuentz M; Hervé P; Tiberghien P; Robinet E
    Exp Hematol; 2001 Apr; 29(4):458-70. PubMed ID: 11301186
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interferon beta decreases T cell activation and interferon gamma production in multiple sclerosis.
    Noronha A; Toscas A; Jensen MA
    J Neuroimmunol; 1993 Jul; 46(1-2):145-53. PubMed ID: 8360326
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Defective production of anti-inflammatory cytokine, TGF-beta by T cell lines of patients with active multiple sclerosis.
    Mokhtarian F; Shi Y; Shirazian D; Morgante L; Miller A; Grob D
    J Immunol; 1994 Jun; 152(12):6003-10. PubMed ID: 8207225
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [T-cell interferon-gamma, tumor necrosis factor-alpha and interleukin-6 receptor binding in patients with multiple sclerosis. Effects of interferon-beta-1b treatment].
    Bongioanni P; Romano MR; Boccardi B; Lombardo F; Moscato G; Mosti S; Baldini C; Nuti S; Meucci G; Rossi B
    Rev Neurol; 1999 Nov 16-30; 29(10):893-9. PubMed ID: 10637835
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Host defensive, immunological, and microbiological observations of an early-onset periodontitis patient with virus-associated hemophagocytic syndrome.
    Kono T; Takigawa M; Nishimura F; Takashiba S; Nakagawa M; Maeda H; Arai H; Nagai A; Kurihara H; Murayama Y
    J Periodontol; 1997 Dec; 68(12):1223-30. PubMed ID: 9444599
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD4+ T cells of schistosomiasis naturally resistant individuals living in an endemic area produce interferon-gamma and tumour necrosis factor-alpha in response to the recombinant 14KDA Schistosoma mansoni fatty acid-binding protein.
    Brito CF; Caldas IR; Coura Filho P; Correa-Oliveira R; Oliveira SC
    Scand J Immunol; 2000 Jun; 51(6):595-601. PubMed ID: 10849370
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Independent regulation of IFN-gamma and tumor necrosis factor by IL-1 in human T helper cells.
    Fischer H; Hedlund G; Kalland T; Sjögren HO; Dohlsten M
    J Immunol; 1990 Dec; 145(11):3767-72. PubMed ID: 2147201
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interferon-gamma, interleukin-4 and transforming growth factor-beta mRNA expression in multiple sclerosis and myasthenia gravis.
    Link J
    Acta Neurol Scand Suppl; 1994; 158():1-58. PubMed ID: 7732782
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential susceptibility to activation-induced apoptosis among peripheral Th1 subsets: correlation with Bcl-2 expression and consequences for AIDS pathogenesis.
    Ledru E; Lecoeur H; Garcia S; Debord T; Gougeon ML
    J Immunol; 1998 Apr; 160(7):3194-206. PubMed ID: 9531275
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interferon-beta 1b treatment decreases tumor necrosis factor-alpha and increases interleukin-6 production in multiple sclerosis.
    Brod SA; Marshall GD; Henninger EM; Sriram S; Khan M; Wolinsky JS
    Neurology; 1996 Jun; 46(6):1633-8. PubMed ID: 8649562
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Age-related impairment of human T lymphocytes' activation: specific differences between CD4(+) and CD8(+) subsets.
    Schindowski K; Fröhlich L; Maurer K; Müller WE; Eckert A
    Mech Ageing Dev; 2002 Feb; 123(4):375-90. PubMed ID: 11744048
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased in vitro induced CD4+ and CD8+ T cell IFN-gamma and CD4+ T cell IL-10 production in stable relapsing multiple sclerosis.
    Brod SA; Nelson LD; Khan M; Wolinsky JS
    Int J Neurosci; 1997 Aug; 90(3-4):187-202. PubMed ID: 9352427
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interleukin-10-secreting CD4 cells from aged patients with AIDS decrease in-vitro HIV replication and tumour necrosis factor alpha production.
    Andrade RM; Lima PG; Filho RG; Hygino J; Milczanowski SF; Andrade AF; Lauria C; Brindeiro R; Tanuri A; Bento CA
    AIDS; 2007 Aug; 21(13):1763-70. PubMed ID: 17690575
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interferon (IFN)-beta treatment enhances CD95 and interleukin 10 expression but reduces interferon-gamma producing T cells in MS patients.
    Rep MH; Schrijver HM; van Lopik T; Hintzen RQ; Roos MT; Adèr HJ; Polman CH; van Lier RA
    J Neuroimmunol; 1999 Apr; 96(1):92-100. PubMed ID: 10227428
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunomodulatory effects of interferon-beta-1b in patients with multiple sclerosis.
    Ossege LM; Sindern E; Patzold T; Malin JP
    Int Immunopharmacol; 2001 Jun; 1(6):1085-100. PubMed ID: 11407304
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lymphocyte subpopulations, oxidative burst and apoptosis in peripheral blood cells of patients with multiple sclerosis-effect of interferon-beta.
    Mix E; Stefan K; Höppner J; Klauer T; Zettl UK; Strauss U; Meyer-Rienecker HJ; Rolfs A
    Autoimmunity; 2003 Aug; 36(5):291-305. PubMed ID: 14567559
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiple sclerosis is associated with an imbalance between tumour necrosis factor-alpha (TNF-alpha)- and IL-10-secreting blood cells that is corrected by interferon-beta (IFN-beta) treatment.
    Ozenci V; Kouwenhoven M; Huang YM; Kivisäkk P; Link H
    Clin Exp Immunol; 2000 Apr; 120(1):147-53. PubMed ID: 10759776
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Production of tumor necrosis factor-alpha and interferon-gamma from human peripheral blood lymphocytes by MGN-3, a modified arabinoxylan from rice bran, and its synergy with interleukin-2 in vitro.
    Ghoneum M; Jewett A
    Cancer Detect Prev; 2000; 24(4):314-24. PubMed ID: 11059563
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of cytokine production, screening of lymphocyte subset patterns and in vitro apoptosis in healthy and Alzheimer's Disease (AD) individuals.
    Lombardi VR; García M; Rey L; Cacabelos R
    J Neuroimmunol; 1999 Jun; 97(1-2):163-71. PubMed ID: 10408971
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.